D-0493-2023 Class II Terminated

Recalled by RemedyRepack Inc. — Indiana, PA

FDA drug recall D-0493-2023 was initiated by RemedyRepack Inc. on Mar 20, 2023 and is designated Class II. Reason for recall: cGMP Deviations The recall status is terminated (terminated Oct 19, 2023). Affected quantity: a) 147 bottles, b)70 bottles, c) 3 bottles.

Recall details

Product Type
Drugs
Report Date
Apr 12, 2023
Initiation Date
Mar 20, 2023
Termination Date
Oct 19, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
a) 147 bottles, b)70 bottles, c) 3 bottles

Product description

Glimepiride 2 mg tablets, packaged in a) 30-count bottles (NDC 70518-0405-03), b) 90-count bottles (NDC 70518-0405-00) and c)180-count bottles (NDC 70518-0405-02), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701

Reason for recall

cGMP Deviations

Distribution pattern

RemedyRepack distributed product to consignees nationwide within the United States

Code information

Lot #: a) J0674153-010923, Exp. Date 01/31/2024; J0649447-092822, Exp. Date 10/31/2023; J0644887-090722, Exp. Date 09/30/2023; J0627309-062222, Exp. Date 06/30/2023; J0622569-060222, Exp. Date 06/30/2023. b) B1646259-041222, Exp. Date 04/30/2023; B2032846-122722, Exp. Date 01/31/2025 B2018675-121722, Exp. Date 05/31/2025; B1708230-060122, B1709748-060122, Exp. Date 06/30/2023; B1692572-051822, Exp. Date 05/31/2023; B1803110-081122, Exp. Date 12/31/2024. c) B1820672-082422, B1814883-082022, Exp. Date 09/30/2024.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0493-2023
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0493-2023. Report a data issue: hello@regdatalab.com.